Differential accumulation of soluble amyloid β peptides 1-40 and 1-42 in human monocytic and neuroblastoma cell lines. Implications for cerebral amyloidogenesis

Cell and Tissue Research

Volumn 298, Issue 2, 1999, Pages 225-232

  Morelli, L ^a,b   Castaño, Eduardo M ^a,b   Prat, M I ^c  

^a Instituto de Quimica y Fisicoquimica Biologicas Buenos Aires   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Aging; Alzheimer's disease; Cell culture; Dementia; Human; Microglia; Neuron

Indexed keywords

AMYLOID BETA PROTEIN; IODINE 125; ISOPROTEIN;

ADSORPTION; ALZHEIMER DISEASE; ARTICLE; COCULTURE; HUMAN; HUMAN CELL; INTERNALIZATION; MONOCYTE; NERVE DEGENERATION; NEUROBLASTOMA CELL; NEUROTOXICITY; PRIORITY JOURNAL;

ADSORPTION; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID NEUROPATHIES; CELL LINE; COCULTURE TECHNIQUES; HUMANS; IODINE RADIOISOTOPES; MONOCYTES; NEUROBLASTOMA; PEPTIDE FRAGMENTS; PROTEIN ISOFORMS; TUMOR CELLS, CULTURED;

EID: 0032712028     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004419900109     Document Type: Article

References (49)

1. Ard MD, Cole GM, Wei J, Mehrle AP, Fratkin JD (1996) Scavenging of Alzheimer's amyloid β-protein by microglia in culture. J Neurosci Res 43:190-202
2. Bitting L, Naidu A, Cordell B, Murphy GM Jr (1996) β-Amyloid peptide secretion by a microglial cell line is induced by β-amyloid-(25-35) and lipopolyssaccharide. J Biol Chem 271: 16084-16089
3. Boland K, Behrens M, Choi D, Manias K, Perlmutter DH (1996) The serpin-enzyme complex receptor recognizes soluble, nontoxic amyloid-β peptide but not aggregated, cytotoxic amyloid-β peptide. J Biol Chem 271:18032-18044
4. Burdick D, Soreghan B, Kwon M, Komoski J, Knauer M, Henschen A, Yates J, Cotman C, Glabe C (1992) Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs. J Biol Chem 267:546-554
5. Burdick D, Kosmoski J, Knauer MF, Glabe CG (1997) Preferential adsoption, internalization and resistance to degradation of the major isoform of the Alzheimer's amyloid peptide, Aβ1-42, in differentiated PC12 cells. Brain Res 74:6275-284
6. Cook DG, Forman MS, Sung JC, Kolson DL, Iwatsubo T, Lee VM-Y, Doms RW (1997) Alzheimer's Aβ(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nature Med 3:1021-1023
7. Dehouck MP, Jolliet-Riant P, Bree F, Fruchart JC, Cecchelli R, Tillement JP (1992) Drug transfer across the BBB: correlation between in vitro and in vivo models. J Neurochem 58:1790-1797
8. Frackowiak J, Wisniewski HM, Wegiel J, Merz GS, Iqbal K, Wang KC (1992) Ultrastructure of the microglia that phagocyte amyloid and the microglia that produce β-amyloid fibrils. Acta Neuropathol 84:225-233
9. Gasque P, Fontaine M, Morgan BP (1995) Complement expression in human brain. Biosynthesis of terminal pathway components and regulators in human glial cells and cell lines. J Immunol 154: 4726-4733
10. Geula C, Wu C, Saroff D, Lorenzo A, Yuan M, Yankner BA (1998) Aging renders the brain vulnerable to amyloid β-protein neurotoxicity. Nature Med 4:827-831
11. Glenner GG, Wong CW (1984) Alzheimer's disease and Down's syndrome sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 120:885-890
12. Goodwin JL, Uemura E, Cunnick JE (1995) Microglial release of nitric oxide by the synergistic action of β-amyloid and TFG-γ. Brain Res 692:207-214
13. Haass C, Schlossmacher M, Hung A, Vigo-Pelfrey C, Mellon A, Ostaszewski B, Lieberbug Y, Koo E, Schenk D, Teplow D, Selkoe D (1992) Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359:322-325
14. Harper J, Lansbury PT Jr (1997) Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem 66:385-407
15. Hartmann T, Bieger SC, Bruhl B, Tienari PJ, Ida N, Allsop D, Roberts G, Masters CL, Dotti CG, Unsicker K, Beyreuther K (1997) Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides. Nature Med 3:1016-1020
16. Hoshi M, Takashima A, Murayama M, Yasutake K, Yoshida N, Ishiguro K, Hoshino T, Imahori K (1997) Nontoxic amyloid β peptide 1-42 supress acetylcholine synthesis. J Biol Chem 272:2038-2041
17. Ida N, Masters C, Beyreuther K (1996) Rapid cellular uptake of Alzheimer amyloid βA4 peptide by cultured human neuroblastoma cells. FEBS Lett 394:174-178
18. Ii M, Sunamoto M, Ohnishi K, Ichimori Y (1996) β-Amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity. Brain Res 720: 93-100
19. Jarret JT, Lansbury PT Jr (1993) Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73: 1055-1058
20. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Muller-Hill B (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733-736
21. Kato M, Saito H, Abe K (1997) Nanomolar amyloid β protein-induced inhibition of cellular redox activity in cultured astrocytes. J Neurochem 68:1889-1895
22. Klegeris A, Walker DG, McGeer P (1997) Interaction of Alzheimer's β-amyloid peptide with the human monocytic cell line THP-1 results in a protein kinase C-dependent secretion of tumor necrosis factor-α. Brain Res 747:114-121
23. Knauer MF, Soreghan B, Burdick D, Kosmoski J, Glabe CG (1992) Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/β protein. Proc Natl Acad Sci USA 89:7437-7441
24. Kuo YM, Emmerling MR, Vigo-Pelfrey C, Kasunic TC, Kirkpatrick JB, Murdoch GH, Ball MJ, Roher AE (1996) Water-soluble Aβ (N-40, N-42) oligomers in normal and Alzheimer's disease brains. J Biol Chem 271:4077-4081
25. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovzky Y, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA (1998) Diffusible, non-fribrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95: 6448-6453
26. Lee SJ, Liyanage U, Bickel PE, Xia W, Lansbury PT Jr, Kosik KS (1998) A detergent-insoluble membrane compartment contains Aβ in vivo. Nature Med 6: 730-734
27. Lorton D, Kocsis JM, King L, Madden K, Brunden KR (1996) β-Amyloid induces increased release of interleukin-1β from lipopolysaccharide-activated human monocytes. J Immunol 67: 21-29
28. McKee AC, Kowall NW, Schumacher JS, Flint Beal M (1998) The neurotoxicity of amyloid beta protein in aged primates. Amyloid. Int J Exp Clin Invest 5:1-9
29. Miller DL, Papayannopoulos IA, Styles J, Bobin SA, Lin YY, Biemann K, Iqbal K (1993) Peptide composition of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch Biochem Biophys 301: 41-52
30. Morelli L, Giambartolomei GH, Prat MT, Castaño EM (1999) Internalization and resistance to degradation of Alzheimer's Aβ1-42 at nanomolar concentrations in THP-1 human monocytic cell line. Neurosci Lett 262: 5-8
31. Narita M, Holtzman DM, Schartz AL, Bu G (1997) α2-Macroglobulin complexes with and mediates the endocytosis of β-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. J Neurochem 69:1904-1911
32. Neill D, Hughes D, Edwardson JA, Rima BK, Allsop D (1994) Human IMR-32 neuroblastoma cells as a model cell line in Alzheimer's disease research. J Neurosci Res 39:482-193
33. Paresce DM, Ghosh RN, Maxfield R (1996) Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a scavenger receptor. Neuron 17:553-565
34. Paresce DM, Chung H, Maxfield FR (1997) Slow degradation of aggregates of the Alzheimer's disease amyloid β-protein by microglial cells. J Biol Chem 272:29390-29397
35. Pike CJ, Walencewicz AJ, Glabe CG, Cotman CW (1991) In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res 563:311-314
36. Pike CJ, Burdick D, Walencewicz. AJ, Glabe C, Cotman CW (1993) Neurodegeneration induced by β-amyloid peptide in vitro: the role of peptide assembly state. J Neurosci 13:1676-1687
37. Podlisny MB, Walsh D, Amarante P, Ostaszewski BL, Stimson ER, Maggio JE, Teplow DB, Selkoe DJ (1998) Oligomerization of endogenous and synthetic amyloid β-protein at nanomolar levels in cell culture and stabilization of monomer by congo red. Biochemistry 37:3602-3611
38. Roth J (1975) Methods for assessing immunologic and biologic properties of iodinated peptide hormones. Methods Enzymol 37:223-228
39. Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W, Larson E, Levy-Lahad E, Viitanen M, Peskind E, Poorkaj P. Schellenberg G, Tanzi R, Wasco W, Lannfelt L, Selkoe D, Younkin S (1996) Secreted amyloid β-protein similar to that in the senile plaque of Alzheimer's disease is increased in vivo by presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med 2: 864-870
40. Selkoe DJ (1996) Amyloid β-protein and the genetics of Alzheimer's disease. J Biol Chem 271:18295-18298
41. Skovronsky DM, Doms RW, Lee VM (1998) Detection of a novel intraneuronal pool of insoluble beta protein that accumulates with time in culture. J Cell Biol 41: 1031-1039
42. Soto C, Castaño EM (1996) The conformation of Alzheimer's β peptide determines the rate of amyloid formation and its resistance to proteolysis. Biochem J 314:701-707
43. Soto C, Sigurdsson EM, Morelli L, Kumar RA, Castaño EM, Frangione B (1998) β-Sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nature Med 4:822-825
44. Suzuki N, Cheung TT, Cal XD, Odaka A, Otvos L Jr, Eckman C, Golde TE, Younkin SG (1994) An increased percentage of long amyloid β protein is secreted by familial amyloid β protein precursor (βAPP717) mutants. Science 359:1336-1340
45. Wujek JR, Dority MD, Frederickson RCA, Brunden KR (1996) Deposits of Aβ fibrils are not toxic to cortical and hippocampal neurons in vitro. Neurobiol Aging 17:107-113
46. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM (1996) RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382:685-691
47. Yan SD, Soto C, Chen X, Al-Mohanna F, Collison K, Zhu A, Stern E, Saido T, Tohyama M, Ogawa S, Roher A, Stern D (1997) An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease. Nature 389:689-695
48. Yankner BA (1996) Mechanism of neuronal degeneration in Alzheimer's disease. Neuron 16:921-932
49. Zhao X, Valantas JA, Vyas S, Duffy LK (1993) Comparative toxicity of amyloid β-peptide in neuroblastoma cell lines: effects of albumin and physalaemin. Comp Biochem Physiol 106: 165-170